Market Place
Sourcing Support
Celyad Oncology announces intention to terminate SEC reporting obligations
08 Feb 2024 //
GLOBENEWSWIRE
Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
16 Jan 2024 //
GLOBENEWSWIRE
Publication of transparency notification received from Fortress Investment Group
20 Dec 2023 //
GLOBENEWSWIRE
Information on the Total Number of Voting Rights and Shares
15 Dec 2023 //
GLOBENEWSWIRE
Publication of a transparency notification received from Tolefi SA
01 Dec 2023 //
GLOBENEWSWIRE
Publication of a transparency notification received from Fortress Investment
21 Nov 2023 //
GLOBENEWSWIRE
Information on the Total Number of Voting Rights and Shares
14 Nov 2023 //
GLOBENEWSWIRE
Celyad Oncology reports third quarter 2023 financial results
09 Nov 2023 //
GLOBENEWSWIRE
Celyad announces the termination of its American Depository Receipt program
25 Sep 2023 //
GLOBENEWSWIRE
Publication of a transparency notification received from Tolefi SA
12 Sep 2023 //
GLOBENEWSWIRE
Publication of a transparency notification received from Fortress Investment
07 Sep 2023 //
GLOBENEWSWIRE
Information on the Total Number of Voting Rights and Shares
05 Sep 2023 //
GLOBENEWSWIRE
Celyad Oncology Reports First Half 2023 Financial Results
04 Sep 2023 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.